TSE:APHA - Aphria Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$18.34
  • Forecasted Upside: 10.81 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$16.55
▼ -0.98 (-5.59%)
1 month | 3 months | 12 months
Get New Aphria Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APHA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APHA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$18.34
▲ +10.81% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Aphria in the last 3 months. The average price target is C$18.34, with a high forecast of C$28.00 and a low forecast of C$10.75. The average price target represents a 10.81% upside from the last price of C$16.55.

Hold

The current consensus among 6 investment analysts is to hold stock in Aphria. This rating has held steady since January 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/21/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/19/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/17/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/16/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/13/2021Canaccord GenuityDowngradeSpeculative Buy ➝ HoldC$17.50
i
4/13/2021Haywood SecuritiesLower Price TargetHoldC$26.00 ➝ C$20.00
i
4/13/2021Pi FinancialDowngradeBuy ➝ NeutralC$11.00 ➝ C$16.00
i
4/13/2021Standpoint ResearchLower Price TargetNeutralC$22.00 ➝ C$18.00
i
4/12/2021CIBCBoost Price TargetOutperformC$28.00
i
4/6/2021Stifel NicolausBoost Price TargetC$15.50 ➝ C$22.00
i
1/19/2021Stifel NicolausBoost Price TargetC$9.80 ➝ C$15.50
i
1/15/2021Alliance Global PartnersSet Price TargetC$20.00
i
1/15/2021Haywood SecuritiesDowngradeBuy ➝ HoldC$12.25 ➝ C$14.00
i
1/15/2021Canaccord GenuityUpgradeHold ➝ Speculative BuyC$11.00 ➝ C$17.50
i
1/15/2021CIBCBoost Price TargetC$12.50 ➝ C$18.00
i
12/18/2020CormarkBoost Price TargetC$8.00 ➝ C$10.75
i
12/18/2020Canaccord GenuityDowngradeSpeculative Buy ➝ Hold
i
12/17/2020Pi FinancialSet Price TargetBuyC$11.00
i
12/17/2020Stifel NicolausDowngradeBuy ➝ HoldC$8.25 ➝ C$9.80
i
12/17/2020Alliance Global PartnersBoost Price TargetC$9.00 ➝ C$12.00
i
12/4/2020Jefferies Financial GroupBoost Price TargetC$9.42 ➝ C$12.80
i
12/2/2020Haywood SecuritiesBoost Price TargetC$8.25 ➝ C$12.25
i
11/13/2020CormarkBoost Price TargetC$7.00 ➝ C$8.00
i
11/9/2020Pi FinancialBoost Price TargetBuyC$10.00 ➝ C$11.00
i
11/5/2020Canaccord GenuityBoost Price TargetC$10.00 ➝ C$11.00
i
10/22/2020Jefferies Financial GroupLower Price TargetC$10.00 ➝ C$9.42
i
10/16/2020CormarkBoost Price TargetC$6.00 ➝ C$7.00
i
10/16/2020CIBCBoost Price TargetC$7.50 ➝ C$8.00
i
10/16/2020Pi FinancialSet Price TargetBuyC$10.00
i
10/9/2020Stifel NicolausBoost Price TargetC$8.00 ➝ C$8.25
i
8/5/2020Jefferies Financial GroupLower Price TargetC$9.00 ➝ C$7.00
i
7/30/2020Pi FinancialBoost Price TargetBuyC$8.00 ➝ C$10.00
i
7/30/2020CIBCBoost Price TargetC$6.00 ➝ C$7.50
i
4/16/2020CIBCLower Price TargetC$7.00 ➝ C$6.00
i
4/16/2020Eight CapitalUpgradeNeutral ➝ BuyC$9.00 ➝ C$8.00
i
4/16/2020Jefferies Financial GroupLower Price TargetC$10.00 ➝ C$9.00
i
4/16/2020Stifel NicolausBoost Price TargetC$4.50 ➝ C$5.30
i
4/14/2020Pi FinancialSet Price TargetBuyC$8.00
i
3/19/2020Bank of AmericaUpgradeNeutral ➝ Buy
i
2/19/2020Bryan, Garnier & CoLower Price TargetC$12.40 ➝ C$6.50
i
1/21/2020Alliance Global PartnersReiterated RatingBuyC$11.00
i
1/20/2020Jefferies Financial GroupLower Price TargetC$11.00 ➝ C$10.30
i
1/15/2020Pi FinancialLower Price TargetBuyC$9.00 ➝ C$8.00
i
1/15/2020CIBCUpgradeUnderperform ➝ NeutralC$6.50 ➝ C$7.00
i
10/16/2019CormarkLower Price TargetC$14.00 ➝ C$8.00
i
10/16/2019Eight CapitalLower Price TargetC$11.00 ➝ C$9.00
i
10/16/2019CIBCLower Price TargetC$7.00 ➝ C$6.50
i
10/11/2019Jefferies Financial GroupLower Price TargetC$15.00 ➝ C$11.00
i
8/2/2019CIBCBoost Price TargetC$6.50 ➝ C$7.00
i
7/26/2019CIBCLower Price TargetC$12.00 ➝ C$6.50
i
6/19/2019Canaccord GenuityLower Price TargetC$18.00 ➝ C$16.00
i
5/24/2019Jefferies Financial GroupReiterated RatingBuyC$15.00
i
4/17/2019CormarkLower Price TargetC$15.00 ➝ C$14.00
i
4/16/2019CIBCBoost Price TargetC$10.00 ➝ C$12.00
i
10/14/2018Bryan, Garnier & CoSet Price TargetBuyC$31.00
i
7/18/2018Canaccord GenuityLower Price TargetC$11.25C$25.50 ➝ C$24.50
i
1/30/2018Canaccord GenuityBoost Price TargetC$23.50 ➝ C$26.50
i
1/11/2018Canaccord GenuitySet Price TargetSpeculative BuyC$23.00
i
1/11/2018Pi FinancialBoost Price TargetC$14.00 ➝ C$25.00
i
12/5/2017Canaccord GenuityBoost Price TargetC$8.25 ➝ C$14.00
i
(Data available from 6/14/2016 forward)
Aphria logo
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Read More

Today's Range

Now: C$16.55
C$16.41
C$17.52

50 Day Range

MA: C$17.96
C$16.52
C$23.09

52 Week Range

Now: C$16.55
C$3.93
C$40.93

Volume

9,609,357 shs

Average Volume

6,161,365 shs

Market Capitalization

C$5.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Aphria?

The following Wall Street sell-side analysts have issued reports on Aphria in the last twelve months: Alliance Global Partners, Canaccord Genuity, CIBC, Cormark, Haywood Securities, Jefferies Financial Group Inc., Pi Financial, Standpoint Research, and Stifel Nicolaus.
View the latest analyst ratings for APHA.

What is the current price target for Aphria?

9 Wall Street analysts have set twelve-month price targets for Aphria in the last year. Their average twelve-month price target is C$18.34, suggesting a possible upside of 10.8%. CIBC has the highest price target set, predicting APHA will reach C$28.00 in the next twelve months. Cormark has the lowest price target set, forecasting a price of C$10.75 for Aphria in the next year.
View the latest price targets for APHA.

What is the current consensus analyst rating for Aphria?

Aphria currently has 5 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in APHA, but not buy more shares or sell existing shares.
View the latest ratings for APHA.

What other companies compete with Aphria?

How do I contact Aphria's investor relations team?

Aphria's physical mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company's listed phone number is 844-427-4742. The official website for Aphria is www.aphria.com.